Sabby Management’s Pfizer PFE Stock Holding History

Sabby Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,322,658	Closed	-$42.1M	–	318
2014 Q4	$39.1K	Buy	+1,322,658	New	+$37.9M	1.23%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sabby Management's PFE Position: Q1 2015 in Review

Sabby Management sold out of Pfizer (PFE) in Q1 2015, closing a stake of 1,322,658 shares — an estimated $42.1M sold.

Sabby Management first reported a position in PFE in Q4 2014 and held it in 1 quarter. The position peaked at $39.1K in Q4 2014. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Sabby Management reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
Sabby Management sold 1,322,658 Pfizer shares in Q1 2015, an estimated $42.1M.
Sabby Management first reported a position in Pfizer in Q4 2014 and held it in 1 quarter.
Sabby Management's Pfizer position peaked at $39.1K in Q4 2014.
1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Sabby Management's 13F filing for Q1 2015, filed 15 May 2015.